An abalone-derived modified antimicrobial peptide AB-1, its preparation and application
By modifying the abalone-derived antimicrobial peptide Abhisin, a novel antimicrobial peptide AB-1 was designed, which solved the problems of meat product spoilage and multidrug-resistant bacteria during low-temperature storage, achieving efficient and safe food preservation.
Patent Information
- Application Number
- CN202310903467.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-07-22
- Publication Date
- 2026-11-17
- Estimated Expiration
- 2043-07-22
AI Technical Summary
Existing meat products are prone to spoilage during low-temperature storage. Chemical preservatives pose food safety risks, physical preservation technologies affect quality, and the spread of multidrug-resistant bacteria is difficult to control effectively.
A novel antimicrobial peptide AB-1 derived from abalone was designed by truncating, substituting, and hybridizing the amino acid sequence of the natural antimicrobial peptide Abhisin to optimize its hydrophobicity and charge, thus forming AB-1 with an α-helix structure.
AB-1 exhibits highly efficient and broad-spectrum antibacterial activity against a variety of foodborne spoilage pathogens and drug-resistant bacteria. It is low in toxicity, resistant to different salt ions and high temperatures, and can disrupt the cell membrane structure of bacteria, thus achieving safe preservation and freshness of food.
Smart Images

Figure FT_1 
Figure FT_2 
Figure FT_3
Abstract
Description
Technical Field
[0001] This invention relates to an abalone-derived modified antimicrobial peptide AB-1, its preparation and application, and belongs to the field of food biotechnology. Background Technology
[0002] Meat products are delicious and nutritious, but due to their high protein and water content, they are prone to autolysis, oxidation, and microbial growth and metabolism, leading to spoilage and food safety issues. Among these factors, the inability to effectively inhibit the growth, reproduction, and metabolic activities of low-temperature spoilage bacteria such as *Pseudomonas*, *Acinetobacter*, and *Microbacterium* during low-temperature storage is the primary cause of meat spoilage. Simultaneously, the overuse of antibiotics in livestock farming has led to the emergence of multidrug-resistant bacteria (MDRs) in many farm animals, meat, and meat products. Common MDRs include broad-spectrum β-lactamase (ESBL) Enterobacteriaceae, methicillin-resistant Staphylococcus aureus (MRSA), and vancomycin-resistant enterococci (VRE). Therefore, the livestock farming and meat processing industry chain has become a significant source of the widespread transmission of multidrug-resistant bacteria to humans. Chemical preservatives pose food safety risks and can cause side effects to the human body if used improperly. Meanwhile, physical preservation technologies such as high temperature, ultra-high pressure, ultrasound, and irradiation can easily cause meat quality deterioration. Therefore, there is an urgent need to develop green, safe, and novel food preservatives that can effectively resist foodborne spoilage, pathogens, and multidrug-resistant bacteria.
[0003] Antimicrobial peptides are a class of small molecule polypeptides with antimicrobial activity, typically composed of 12-45 amino acids, and are an important component of the nonspecific immunity of organisms. We know that the main lipid components of bacteria are anionic phosphatidylglycerol and cardiolipin, which have a high negative charge tendency. Mammalian cell membranes are rich in amphoteric molecules such as phosphatidylethanolamine, phosphatidylcholine, and sphingomyelin, which are electrically neutral. Therefore, antimicrobial peptides can selectively interact electrostatically with the negative charge of the microbial membrane. When the antimicrobial peptide binds to the cell membrane at a certain concentration, the antimicrobial peptide undergoes structural or conformational transitions and changes. Positively charged amino acids interact with the hydrophilic "head" of the phospholipid, while hydrophobic amino acids interact with the hydrophobic "tail" of the lipid bilayer, allowing the antimicrobial peptide to deeply insert into the cell membrane and further disrupt it. Most antimicrobial peptides can selectively bind to bacterial cell membranes, thereby disrupting the cell membrane structure or binding across the membrane to intracellular macromolecules to rapidly kill bacteria. This gives antimicrobial peptides the characteristics of highly efficient bactericidal action and low resistance, making them a potential candidate for development into a new generation of "antibiotics" or preservatives.
[0004] Certain physicochemical parameters of antimicrobial peptides, such as net charge, hydrophobicity, structure, and peptide chain length, significantly influence their functional activity. These factors must be fully considered during peptide design to achieve an optimal balance and yield a more desirable synthetic antimicrobial peptide. Currently, antimicrobial peptides are mainly designed and synthesized using two approaches: template modification of natural antimicrobial peptides and de novo design. Natural antimicrobial peptides serve as starting templates for the synthesis of novel antimicrobial peptides. Through sequence truncation, amino acid substitution, hybridization, cyclization, and amidation, antimicrobial peptides with higher activity and selectivity can be obtained. De novo design of antimicrobial peptides primarily involves designing entirely new antimicrobial peptides based on specific physicochemical parameters. Unlike natural antimicrobial peptides, novel antimicrobial peptides are generally shorter, structurally simpler, and contain only specific amino acids with repetitive sequences.
[0005] Abhisin is an antimicrobial peptide containing 40 amino acids at the N-terminus of the histone H2A sequence of the abalone species *Haliotis discus*. Studies have shown that histones or histone-derived peptides possess antimicrobial activity in vertebrates, including humans, amphibians, and marine organisms. Abhisin exhibits the highest amino acid homology (92%) with AMP derived from scallop (*Chlamys farreri*), and 80% and 67% homology with buforin I (*Bufo bufo gargarizans*) and hipposin (*A. halibut*), respectively. Studies have found that 250 mg / mL of Abhisin inhibits the growth of *Listeria monocytogenes*, *Vibrio ferruginosa*, and *Pseudomonas ovalis* yeast. Abhisin possesses typical characteristics of antimicrobial peptides, with a charge of +13, 27% hydrophobic residues, and a protein-binding potential of 2.82 kcal / mol. Furthermore, Abhisin contains a high proportion of arginine and lysine residues. The secondary structure of Abhisin was predicted using the Schiffer-Edmundson helical wheel model, revealing that Abhisin is a linear helical molecule with hydrophobic and hydrophilic residues on either side. Although Abhisin possesses certain antibacterial activity and is green and non-toxic, its long sequence and high synthesis cost result in unsatisfactory antibacterial activity. Based on the above design strategy, a novel antimicrobial peptide with broad-spectrum and highly efficient antimicrobial activity, low toxicity and safety, resistance to cooking (100℃), and tolerance to different salt ions was designed, providing an effective antimicrobial agent for the preservation and storage of meat products. Summary of the Invention
[0006] The purpose of this invention is to address the shortcomings of natural antimicrobial peptides by providing an abalone-derived modified antimicrobial peptide, AB-1, its preparation, and its applications. Antimicrobial peptide AB-1 exhibits highly efficient and broad-spectrum antimicrobial activity against various foodborne spoilage pathogens and drug-resistant bacteria, and is low in toxicity, safe, and exhibits strong tolerance to salt ions.
[0007] To achieve the above objectives, the present invention adopts the following technical solution:
[0008] An abalone-derived modified antimicrobial peptide AB-1, characterized in that: the amino acid sequence of the abalone-derived modified antimicrobial peptide AB-1 is: Arg-Arg-Arg-Leu-Gln-Arg-Pro-Leu-Arg-Arg-Ile-His-Arg-Leu-Leu-Arg-Lys-Ala-Lys-Lys-Phe-Gly-Lys-Ala-Phe-Val-Gly-Glu-Ile-Met.
[0009] Furthermore, the aforementioned abalone-derived modified antimicrobial peptide AB-1 was obtained by modifying the amino acid sequence of the antimicrobial peptide Abhisin. The amino acid sequence of the antimicrobial peptide Abhisin is as follows:
[0010] Met-Ser-Gly-Arg-Gly-Lys-Gly-Gly-Lys-Thr-Lys-Ala-Lys-Ala-Lys-Ser-Arg-Ser-Ser-Arg-Ala-Gly-Leu-Gln-Phe-Pro-Val-Gly-Arg-Ile-His-Arg-Leu-Leu-Arg-Lys-Gly-Asn-Tyr-Ala.
[0011] Furthermore, the design method of the above-mentioned abalone-derived modified antimicrobial peptide AB-1 is as follows: the amino acid sequence of the antimicrobial peptide Abhisin is truncated to remove redundancy, resulting in the sequence RAGLQFPVGRIHRLLRKGNYA; then, the amphiphilicity and charge are optimized by amino acid substitution, resulting in the sequence RRRLQRPLRRIHRLLRKGNYA; and then, the effective fragment AKKFGKAFVGEIM is hybridized to obtain the amino acid sequence RRRLQRPLRRIHRLLRKAKKFGKAFVGEIM of the antimicrobial peptide AB-1.
[0012] Furthermore, the abalone-derived modified antimicrobial peptide AB-1 has a net charge of +30 and a molecular weight of 3731.56 Da.
[0013] Furthermore, the abalone-derived modified antimicrobial peptide AB-1 exhibits low cytotoxicity, maintaining a cell viability of 65.93% at 128 μg / mL, demonstrating high stability and ease of enzymatic hydrolysis.
[0014] The above-mentioned abalone-derived modified antimicrobial peptide AB-1 is used in the preparation of antibacterial agents. The antibacterial effect refers to the inhibition of Escherichia coli, Salmonella, Shigella flexneri, Pseudomonas aeruginosa, Cronobacter sakazakii, Vibrio parahaemolyticus, Staphylococcus aureus, Bacillus pumilus, Micrococcus luteus, and Bacillus cereus.
[0015] The above-mentioned application of the abalone-derived modified antimicrobial peptide AB-1 in food preservation refers to the inhibition of food spoilage bacteria to achieve the purpose of preservation.
[0016] The significant advantages of this invention are:
[0017] The natural abalone-derived antimicrobial peptide Abhisin has been proven to possess certain antimicrobial activity and low cytotoxicity, but its antimicrobial activity against foodborne spoilage pathogens is relatively weak. This invention utilizes the structure-activity relationship and rational design strategy of antimicrobial peptides to modify the natural amino acid sequence of Abhisin, resulting in a novel, highly effective, broad-spectrum, and low-toxicity antimicrobial peptide, AB-1, with an α-helix structure. AB-1 is stable to metal ions, resistant to boiling (100℃), and sensitive to proteases. Furthermore, AB-1 exerts its antimicrobial effect by disrupting the cell wall membrane structure of bacteria, exhibiting significant antimicrobial effects against foodborne spoilage pathogens, including drug-resistant bacteria. Attached image description:
[0018] Figure 1 : Simulated three-dimensional structure diagram of Abhisin.
[0019] Figure 2 High-performance liquid chromatogram of antimicrobial peptide AB-1.
[0020] Figure 3 : Liquid chromatography-mass spectrometry chromatogram of antimicrobial peptide AB-1.
[0021] Figure 4 : Helix diagram of antimicrobial peptide AB-1.
[0022] Figure 5 Circular dichroism chromatogram of antimicrobial peptide AB-1.
[0023] Figure 6 Cytotoxicity of antimicrobial peptide AB-1 against RAW 264.7.
[0024] Figure 7 Flow cytometry analysis of the effect of antimicrobial peptide AB-1 on the cell membrane integrity of MRSAATCC 43300 cells. A, control group; B, 0.5×MIC; C, 1×MIC; D, 2×MIC; E, 4×MIC.
[0025] Figure 8Scanning electron microscope (SEM) images of MRSAATCC 43300 microarrays after treatment with antimicrobial peptide AB-1. A, control group; B, 1×MIC; C, 2×MIC; D, 4×MIC. Detailed Implementation
[0026] To make the content of this invention easier to understand, the technical solution of this invention will be further described below in conjunction with specific embodiments. However, the following examples are merely examples of this invention and do not represent the scope of protection of this invention. The scope of protection of this invention is determined by the claims.
[0027] Example 1
[0028] Abhisin is an antimicrobial peptide derived from the N-terminus of the histone H2A sequence of the discus abalone (Haliotis discus), containing 40 amino acids (MSGRGKGGKTKAKAKSRSSRAGLQFPVGRIHRLLRKGNYA). The three-dimensional structure of Abhisin (…) Figure 1It can be seen that Abhisin contains a linear α-helix structure. Based on secondary structure prediction, the sequence GRIHRLLR is an α-helix region. Therefore, an effective fragment was extracted, resulting in sequence 1 (RAGLQFPVGRIHRLLRKGNYA). Then, appropriate amino acid substitutions were made based on sequence 1. Arginine has a high charge density, and its guanidinium side chain can form strong bidentate hydrogen bonds and salt bridges with the phosphorus-rich membrane surface of bacteria. Leucine not only improves the hydrophobicity of the antimicrobial peptide but also maintains the helical structure of the novel antimicrobial peptide. Therefore, arginine (R) was used to replace the second alanine (A), third glycine (G), sixth phenylalanine (F), and ninth glycine (G) in sequence 1, and leucine (L) was used to replace the eighth valine (V) in sequence 1. This substitution of arginine and leucine increased the positive charge on the polar surface and the hydrophobicity on the non-polar surface of the α-helix antimicrobial peptide, resulting in sequence 2 (RRRLQRPLRRIHRLLRKGNYA). By truncating and hybridizing different types of natural antimicrobial peptides, the advantages of each original peptide can be utilized to obtain ideal novel antimicrobial peptides. Therefore, based on sequence 2, GNYA was truncated and amino acids 9 to 21 of the antimicrobial peptide Magainin 2 were spliced together (AKKFGKAFVGEIM), finally obtaining the antimicrobial peptide AB-1 sequence (RRRLQRPLRRIHRLLRKAKKFGKAFVGEIM). The physicochemical parameters and amino acid sequences of antimicrobial peptides can be predicted online using ExPASyProteomics Server: http: / / www.expasy.org / tools / protparam.html and http: / / aps.unmc.edu / AP / main.php. Secondary structures can be predicted using https: / / www.novopro.cn / tools / secondary-structure-prediction.html, three-dimensional structures can be predicted using https: / / swissmodel.expasy.org / , and helical wheel structures can be predicted using https: / / heliquest.ipmc.cnrs.fr / cgibin / ComputParams.py.
[0029] The antimicrobial peptide AB-1 was synthesized by Shanghai Jier Biochemical Co., Ltd. using the Fmoc solid-phase synthesis method. After purification to a purity greater than 95% by reversed-phase high-performance liquid chromatography (RP-HPLC), its molecular weight was further detected and confirmed by MALDI-TOF mass spectrometry, yielding a molecular weight of 3731.56 Da, indicating that its actual molecular weight is consistent with the theoretical molecular weight. The HPLC chromatogram of antimicrobial peptide AB-1 is shown below. Figure 2 The chromatogram of liquid chromatography-mass spectrometry is shown below. Figure 3 . sprocket ( Figure 4The prediction results showed that most of the cationic amino acids of antimicrobial peptide AB-1 were distributed on the polar side, while most of the hydrophobic amino acids were distributed on the nonpolar side, exhibiting a relatively complete amphiphilic structure with a high positive charge. This incomplete amphiphilicity helps improve antimicrobial activity while reducing cytotoxicity, and the high positive charge facilitates electrostatic interactions, promoting the binding of the antimicrobial peptide to the bacterial membrane. Furthermore, the hydrophobicity of antimicrobial peptide AB-1 increased from 0.037 to 0.1676, and the hydrophobic torque also increased from 0.196 to 0.573 (Table 1), further indicating that the hydrophobicity and amphiphilicity of antimicrobial peptide AB-1 were significantly improved, facilitating its insertion into the cell membrane and the occurrence of hydrophobic interactions.
[0030] Table 1. Amino acid sequence and structural parameters of antimicrobial peptides
[0031] polypeptide AA <![CDATA[NC a ]]> Theoretical MW <![CDATA[Theoretical MW b ]]> <![CDATA[H c ]]> <![CDATA[μHrel d ]]> Abhisin 40 12 4327.09 4326.05 0.037 0.196 AB-1 30 11 3731.56 3731.56 0.1676 0.573
[0032] Note: a. Net positive charge; b. Molecular weight (MW); c. Hydrophobicity (H); d. Hydrophobic torque (μHrel).
[0033] Example 2
[0034] The secondary structure of the antimicrobial peptide AB-1 was detected by circular dichroism spectroscopy (CD spectrum).
[0035] Antimicrobial peptide AB-1 was dissolved in deionized water and 50% trifluoroethanol (TFE, simulating the hydrophobic environment of bacterial cell membranes) to prepare homogeneous solutions of 128 μg / mL. The circular dichroism spectrum (λ = 190–250 nm) of antimicrobial peptide AB-1 was measured using a J-1500 spectropolarimeter (Jasco, Tokyo, Japan), with a path length of 0.1 cm, a temperature of 25 °C, and a frequency of 50 nm / min. Each peptide was scanned three times, and the average value was taken. Results are as follows: Figure 5 As shown in the figure, in aqueous solution, the antimicrobial peptide AB-1 exhibits a negative peak at 198 nm, indicating that the novel antimicrobial peptide presents a randomly coiled structure in aqueous solution. In 50% TFE solution, the novel antimicrobial peptide shows two negative peaks at 208 nm and 222 nm, and a positive peak at 192 nm, indicating that it exhibits an α-helix structure in a simulated cell membrane environment. The disorder-to-order transition of antimicrobial peptide AB-1 in different solutions further illustrates the mechanism of its membrane interaction.
[0036] Example 3
[0037] The antimicrobial activity of the antimicrobial peptide AB-1 was determined by the minimum inhibitory concentration (MIC).
[0038] The bacterial culture stored in glycerol at -20℃ was activated by inoculating it at a 1:100 (v / v) ratio into sterile MHB medium and incubating overnight at 37℃ and 180 rpm / min. The activated bacterial culture was then transferred to sterile MHB medium at a 1:100 (v / v) ratio and incubated at 37℃ and 180 rpm / min until the logarithmic growth phase. The bacterial concentration was adjusted to OD600 of 0.35–0.4 using a UV spectrophotometer (GEN10S UV-VIs), and then diluted 1000 times with MHB, resulting in a bacterial concentration of approximately 10. 5 CFU / mL. Antimicrobial peptide AB-1 was dissolved in sterile deionized water and diluted sequentially in 96-well plates. Then, 50 μL of bacterial culture was mixed with 50 μL of antimicrobial peptide AB-1 solution in 96-well plates and incubated at 37°C for 12–18 h. As shown in Table 2, the MIC values of antimicrobial peptide Abhisin against *Escherichia coli* ATCC 8739 were 16–32 μg / mL, while the MIC value against *Enterohemorrhagic Escherichia coli* O157:H7 CICC 21530, *Staphylococcus aureus* ATCC 6538, and methicillin-resistant *Staphylococcus aureus* ATCC 43300 was 128 μg / mL, indicating unsatisfactory antibacterial activity. In contrast, antimicrobial peptide AB-1 showed better antibacterial activity, with MIC values reaching 2–4 μg / mL.
[0039] Table 2 Antimicrobial activity of antimicrobial peptides
[0040]
[0041] Subsequently, broad-spectrum antibacterial experiments were conducted on the novel antimicrobial peptide AB-1. As shown in Table 3, the antimicrobial peptide AB-1 exhibited broad-spectrum antimicrobial activity, showing antimicrobial activity against a range of Gram-negative bacteria, Gram-positive bacteria, and clinically or foodborne drug-resistant bacteria such as methicillin-resistant Staphylococcus aureus MW2 and methicillin-resistant Staphylococcus aureus N315, with a minimum inhibitory concentration (MIC) between 2 and 16 μg / mL.
[0042] Table 3 Broad-spectrum antibacterial activity of antimicrobial peptide AB-1
[0043] strains Minimum inhibitory concentration (μg / mL) Escherichia coli ATCC8099 4 Escherichia coli CMCC(B)44102 2 Escherichia coli ATCC 25922 2 Salmonella paratyphi B CMCC(B)50094 8 Salmonella paratyphi A CMCC(B)50093 4 Salmonella enteritidis CICC 21527 2 Salmonella choleraesuis CICC 13312 4 Shigella flexneri CMCC51571 4 Pseudomonas aeruginosa ATCC 27853 16 Cronobacter sakazakii ATCC 29544 8 Vibrio parahaemolyticus ATCC 17802 8 Methicillin-resistant Staphylococcus aureus N315 8 Methicillin-resistant Staphylococcus aureus MW2 16 Staphylococcus aureus CMCC 26003 4 Staphylococcus aureus ATCC 29213 8 Staphylococcus aureus ATCC 12600 8 Staphylococcus aureus ATCC 25923 8 Bacillus pumilus CMCC 63202 4 Micrococcus luteus CMCC 28001 4 Bacillus cereus CMCC 63301 8
[0044] It is evident that the antimicrobial activity of antimicrobial peptide AB-1 is significantly enhanced compared to that of antimicrobial peptide Abhisin.
[0045] Example 4
[0046] The cytotoxicity of the antimicrobial peptide AB-1 was detected by the MTT assay.
[0047] RAW264.7 mouse macrophages, extracted from liquid nitrogen, were rapidly thawed in a 37°C water bath. The thawed cells were transferred to 2ml centrifuge tubes and centrifuged at 2000 rpm for 3 minutes. The supernatant was discarded, and the cell pellet was washed with fresh culture medium. The cell pellet was then resuspended in 1ml of fresh culture medium and transferred to a culture flask containing 5ml of culture medium. The flasks were incubated at 37°C, 5% CO2, and 95% humidity for 24 hours. Subsequently, the cells in the culture flasks were washed with 0.01M PBS buffer (pH 7.2), centrifuged (2000 rpm, 3 minutes), and the cells were collected to form a cell suspension for passage. Cells were passaged until they reached good growth status and then plated. The cell suspension concentration was adjusted to 1×10⁻⁶ cells using a hemocytometer during plate formation. 5 Cells were cultured at a density of 100 μL / well to 96-well plates. The plates were incubated at 37°C, 5% CO2, and 95% humidity for 24 h. The culture medium from the 24 h plates was discarded, and 90 μL of fresh culture medium and 10 μL of serially diluted antimicrobial peptide AB-1 were added. The plates were then incubated for another 24 h. 10 μL of 5 mg / mL MTT solution was added, and the plates were incubated for 4 h. The old culture medium was discarded, and 150 μL of dimethyl sulfoxide was added. The plates were incubated with shaking at 600 rpm for 10 min to dissolve the crystals. The absorbance of each well was measured at 570 nm. Results are as follows: Figure 6 As shown, the antimicrobial peptide AB-1 induced low cytotoxicity, with 65.93% of cells still viable at 128 μg / mL.
[0048] Example 5
[0049] Methicillin-resistant Staphylococcus aureus (MRSA) is a strain of Staphylococcus aureus resistant to all β-lactam antibiotics and is widely found in aquatic and terrestrial organisms such as pigs, cattle, and chickens. This invention discovered that the antimicrobial peptide AB-1 has an inhibitory effect on MRSA, therefore MRSAATCC 43300 was selected as the research object to study the effect of antimicrobial peptide AB-1 on MRSAATCC 43300 under different processing environments.
[0050] The effects of the presence of salt ions and heating at 100℃ on the antibacterial activity of antimicrobial peptide AB-1 were determined. After supplementing MHB medium with sodium chloride (150 mM), potassium chloride (4.5 mM), ammonium chloride (6 μM), magnesium chloride (1 mM), calcium chloride (2 mM), zinc chloride (8 μM), or ferric chloride (4 μM), the minimum inhibitory concentration (MIC) of antimicrobial peptide AB-1 under different salt ion conditions was determined. Table 4 shows that different salt ions had little effect on the antimicrobial activity of antimicrobial peptide AB-1, and all experimental groups showed satisfactory antimicrobial activity. Table 5 shows that antimicrobial peptide AB-1 still exhibited high thermal stability even at 100℃.
[0051] Table 4. Effects of salt ions on the antibacterial activity of antimicrobial peptide AB-1
[0052]
[0053] Table 5. Effects of thermal environment (100℃) on the antibacterial activity of antimicrobial peptide AB-1
[0054]
[0055]
[0056] Example 6
[0057] Antimicrobial peptide AB-1 was co-incubated with equal volumes of trypsin or pepsin of different concentrations for 2 hours, followed by inactivation at 100°C for 10 minutes. The enzyme-treated antimicrobial peptide AB-1 was then dilute sequentially in 96-well plates. Subsequently, 50 μL of bacterial culture was mixed with 50 μL of the enzyme-treated antimicrobial peptide AB-1 solution in 96-well plates and incubated at 37°C for 12–18 hours. The results are shown in Table 6. The antibacterial effect of antimicrobial peptide AB-1 decreased under trypsin and pepsin treatment, indicating that antimicrobial peptide AB-1 is easily enzymatically hydrolyzed and has the potential to become a food preservative.
[0058] Table 6. Effects of protease on the antibacterial activity of the novel antimicrobial peptide AB-1
[0059]
[0060] Example 7
[0061] The effects of the antimicrobial peptide AB-1 on the cell membrane were detected by flow cytometry.
[0062] Collect MRSAATCC 43300 cell pellet grown to the logarithmic growth phase, wash repeatedly with PBS solution, and adjust OD. 600The value was approximately 0.40. After diluting 1000 times, 1 mL of bacterial suspension was added to a sterile centrifuge tube, followed by equal volumes of antimicrobial peptide AB-1 at concentrations of 4×MIC, 2×MIC, 1×MIC, and 0.5×MIC. The mixture was incubated for 30 min, and then 15 mmol / L propidium iodide (PI) was added under light-protected conditions. After reacting for 5 min, the bacterial suspension was analyzed using flow cytometry (Accuri C6 Plus). The results showed that in the control group without antimicrobial peptide AB-1, only a weak fluorescence signal was detected. With increasing concentration of antimicrobial peptide AB-1, the fluorescence intensity gradually increased, indicating greater disruption of cell membrane integrity. Flow cytometry results indicated (…). Figure 7 The antimicrobial peptide AB-1 can disrupt the integrity of the MRSAATCC 43300 cell membrane, and the degree of disruption increases with increasing antimicrobial peptide concentration.
[0063] Example 8
[0064] The ultrastructure of bacteria after treatment with the antimicrobial peptide AB-1 can be observed by scanning electron microscopy (SEM).
[0065] Collect MRSAATCC 43300 cell pellet grown to the logarithmic growth phase, wash repeatedly with PBS solution, and adjust OD. 600 The value was approximately 0.08, diluted 100-fold. 100 μL of bacterial suspension and 100 μL of antimicrobial peptide AB-1 were added to each 1.5 mL centrifuge tube and incubated at 37°C for 1 h. Then, the mixture was centrifuged at 3000 rpm for 5 min at 4°C. A certain amount of 2.5% glutaraldehyde was slowly added to the resulting bacterial pellet, and the mixture was fixed at 4°C for 4 h. The bacteria were then thoroughly washed three times with PBS and once with UP water. An appropriate amount of the bacterial suspension was added dropwise to the surface of a silicon wafer (washed with ethanol) and allowed to air dry overnight. The sample was sputter-coated with gold using an ion sputtering apparatus, and the bacteria were imaged using a scanning electron microscope. From... Figure 8 It can be seen that without the addition of antimicrobial peptide AB-1, MRSA ATCC 43300 cells were almost undamaged, plump, and smooth; while after treatment with different concentrations of antimicrobial peptide AB-1, MRSA ATCC 43300 cells showed varying degrees of surface roughness and irregular morphology.
[0066] The above description is only a preferred embodiment of the present invention. All equivalent changes and modifications made within the scope of the claims of the present invention should be included in the scope of the present invention.
Claims
1. An abalone-derived modified antimicrobial peptide AB-1, characterized in that: Its amino acid sequence is as follows: Arg-Arg-Arg-Leu-Gln-Arg-Pro-Leu-Arg-Arg-Ile-His-Arg-Leu-Leu-Arg-Lys-Ala-Lys-Lys-Phe-Gly-Lys-Ala-Phe-Val-Gly-Glu-Ile-Met.
2. The use of the abalone-derived engineered antimicrobial peptide AB-1 according to claim 1 for the preparation of an antibacterial agent, characterized in that: The term "antibacterial" refers to the inhibition of Escherichia coli, Salmonella, Shigella flexneri, Pseudomonas aeruginosa, Cronobacter sakazakii, Vibrio parahaemolyticus, Staphylococcus aureus, Bacillus pumilus, Micrococcus luteus, and Bacillus cereus.
3. The application of the abalone-derived modified antimicrobial peptide AB-1 as described in claim 1 in food preservation.
